Vertex downgraded to Neutral from Buy at H.C. Wainwright H.C. Wainwright downgraded Vertex Pharmaceuticals to Neutral with an $85 price target following yesterday's rally. The firm believes share are appropriately valued at current levels.
News For VRTX From The Last 14 Days
Check below for free stories on VRTX the last two weeks.
Stocks with call strike movement; FSLR VRTX First Solar (FSLR) March 80 call option implied volatility increased 2% to 42, Vertex (VRTX) January 105 call option implied volatility increased 6% to 41 according to IVolatility.